Pleomorphic adenoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| (16 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Pleomorphic adenoma}} | {{Pleomorphic adenoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{M.N}} | ||
==Overview== | ==Overview== | ||
The annual [[Incidence (epidemiology)|incidence]] of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 [[population]]. It accounts for 45-75% of all [[salivary gland]] [[neoplasms]]. [[Females]] are more commonly affected than [[males]]. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The annual incidence of | *The annual [[Incidence (epidemiology)|incidence]] of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 [[population]].<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref> | ||
*It accounts for 45-75% of all salivary gland neoplasms. | *It accounts for 45-75% of all [[salivary gland neoplasms]]. | ||
*Pleomorphic adenoma distribution among the salivary glands is as follows<ref name="pmid27040584">{{cite journal |vauthors=Zhan KY, Khaja SF, Flack AB, Day TA |title=Benign Parotid Tumors |journal=Otolaryngol. Clin. North Am. |volume=49 |issue=2 |pages=327–42 |date=April 2016 |pmid=27040584 |doi=10.1016/j.otc.2015.10.005 |url=}}</ref>: | *Pleomorphic adenoma distribution among the [[salivary glands]] is as follows<ref name="pmid27040584">{{cite journal |vauthors=Zhan KY, Khaja SF, Flack AB, Day TA |title=Benign Parotid Tumors |journal=Otolaryngol. Clin. North Am. |volume=49 |issue=2 |pages=327–42 |date=April 2016 |pmid=27040584 |doi=10.1016/j.otc.2015.10.005 |url=}}</ref>: | ||
**Parotid gland: 84% | **[[Parotid gland]]: 84% | ||
**Submandibular gland: 8% | **[[Submandibular gland]]: 8% | ||
**Minor salivary glands: 6.5% | **Minor [[salivary glands]]: 6.5% | ||
===Age=== | ===Age=== | ||
*People of all age groups may develop | *People of all [[age]] groups may develop pleomorphic adenoma.<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref> | ||
*The incidence of | *The [[Incidence (epidemiology)|incidence]] of pleomorphic adenoma increases with [[age]]; the average [[age]] at [[diagnosis]] is 43-46 years. | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to | *There is no [[racial]] predilection to pleomorphic adenoma. | ||
===Gender=== | ===Gender=== | ||
*Females are predominantly affected by | *[[Females]] are predominantly affected by pleomorphic adenoma than [[males]]. The [[female]] to [[male]] ratio is approximately (2:1)<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref> | ||
=== | |||
=== | |||
==References== | ==References== | ||
| Line 42: | Line 30: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | |||
[[Category: Otolaryngology]] | |||
[[Category: Medicine]] | |||
[[Category: Oncology]] | |||
[[Category: Surgery]] | |||
[[Category: Up-To-Date]] | |||
Latest revision as of 19:29, 28 January 2019
|
Pleomorphic adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pleomorphic adenoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pleomorphic adenoma epidemiology and demographics |
|
Pleomorphic adenoma epidemiology and demographics in the news |
|
Risk calculators and risk factors for Pleomorphic adenoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]
Overview
The annual incidence of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population. It accounts for 45-75% of all salivary gland neoplasms. Females are more commonly affected than males.
Epidemiology and Demographics
Incidence
- The annual incidence of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population.[1]
- It accounts for 45-75% of all salivary gland neoplasms.
- Pleomorphic adenoma distribution among the salivary glands is as follows[2]:
- Parotid gland: 84%
- Submandibular gland: 8%
- Minor salivary glands: 6.5%
Age
- People of all age groups may develop pleomorphic adenoma.[1]
- The incidence of pleomorphic adenoma increases with age; the average age at diagnosis is 43-46 years.
Race
- There is no racial predilection to pleomorphic adenoma.
Gender
- Females are predominantly affected by pleomorphic adenoma than males. The female to male ratio is approximately (2:1)[1]
References
- ↑ 1.0 1.1 1.2 Pinkston JA, Cole P (June 1999). "Incidence rates of salivary gland tumors: results from a population-based study". Otolaryngol Head Neck Surg. 120 (6): 834–40. doi:10.1016/S0194-5998(99)70323-2.
- ↑ Zhan KY, Khaja SF, Flack AB, Day TA (April 2016). "Benign Parotid Tumors". Otolaryngol. Clin. North Am. 49 (2): 327–42. doi:10.1016/j.otc.2015.10.005. PMID 27040584.